Pasireotide for postoperative pancreatic fistula Academic Article uri icon

Overview

MeSH Major

  • Abdominal Abscess
  • Pancreatic Fistula
  • Postoperative Complications
  • Somatostatin

abstract

  • Perioperative treatment with pasireotide decreased the rate of clinically significant postoperative pancreatic fistula, leak, or abscess. (Funded by Novartis Pharmaceuticals; ClinicalTrials.gov number, NCT00994110.).

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1313688

PubMed ID

  • 24849084

Additional Document Info

start page

  • 2014

end page

  • 22

volume

  • 370

number

  • 21